SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-118186
Filing Date
2016-08-11
Accepted
2016-08-11 09:25:30
Documents
36
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445016_10q.htm 10-Q 449877
2 EXHIBIT 31.1 v445016_ex31-1.htm EX-31.1 7053
3 EXHIBIT 31.2 v445016_ex31-2.htm EX-31.2 7038
4 EXHIBIT 32.1 v445016_ex32-1.htm EX-32.1 3670
5 EXHIBIT 32.2 v445016_ex32-2.htm EX-32.2 3654
  Complete submission text file 0001144204-16-118186.txt   4406789

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20160630.xml EX-101.INS 1193401
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20160630.xsd EX-101.SCH 33987
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20160630_cal.xml EX-101.CAL 21690
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20160630_def.xml EX-101.DEF 169725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20160630_lab.xml EX-101.LAB 238429
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20160630_pre.xml EX-101.PRE 190729
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 161823178
SIC: 2836 Biological Products, (No Diagnostic Substances)